[1] Raut, S.S., sharma, A., Mishra, P.K. et al. Isolation and characterization of novel bacterial strain from sewage sludge and exploring its potential for hydrogen production. Arch Microbiol 207, 10 (2025). https://doi.org/10.1007/s00203-024-04211-0
[2] Singh, V., Kumar, A., Mishra, V., & Rai, S.N. (Eds.). (2024). Heavy Metal Contamination in the Environment: Health Impacts and Potential Remediation Approaches (1st ed.). CRC Press. https://doi.org/10.1201/9781032685793
[3] Sharma, A., Raut, S.S., Shukla, A. Mishra, A. DDX3X dynamics, glioblastoma's genetic landscape, therapeutic advances, and autophagic interplay. Med Oncol 41, 258 (2024). https://doi.org/10.1007/s12032-024-02525-z
[4] Raut, S.S., Mishra, A. (2024). Gamma Radiation-Based Technologies for Waste Biomass Valorization: Mechanism, Instrument Design, Recent Technical Advances, Limitations, and Future Aspect. In: Verma, P., Kumar, B. (eds) Sustainable Radiation Technologies in Waste-biomass Valorization. Green Chemistry and Sustainable Technology. Springer, Cham. https://doi.org/10.1007/978-3-031-63941-8_10
[5] Sharma, A., Raut, S.S., Dhikale, P., Khushboo, Mishra, A. (2024). Navigating the Landscape of Cancer-Induced Thrombocytopenia: Current Challenges and Emerging Advances. In: Verma, P. (eds) Industrial Microbiology and Biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-97-6270-5_14
[6] A. D. Tripathi, Y. Labh, S. Katiyar, A. K. Singh, V. K. Chaturvedi, and A. Mishra, “Folate-Mediated Targeting and Controlled Release: PLGA-Encapsulated Mesoporous Silica Nanoparticles Delivering Capecitabine to Pancreatic Tumor,” ACS Appl. Bio Mater., Mar. 2024, doi: 10.1021/acsabm.4c00019.
[7] Tripathi, A.D., Labh, Y., Katiyar, S. et al. Advancements in Nano-Mediated Biosensors: Targeting Cancer Exosome Detection. J Clust Sci 35, 2195–2212 (2024). https://doi.org/10.1007/s10876-024-02676-z
[8] A. D. Tripathi, V. K. Pandey, S. Katiyar, and A. Mishra, “The Emerging Role of Biosensors in the Identification, Characterization, and use of Natural Bioactive Compounds,” in Recent Advances in Biosensor Technology: Volume 2, Bentham Science Publishers, 2023, pp. 1–15. Accessed: Dec. 29, 2024. [Online]. Available: DOI: https://doi.org/10.2174/97898151237391230101https://www.benthamdirect.com/content/books/9789815136418.chap1
[9] S. Katiyar, A. D. Tripathi, R. K. Singh, A. Kumar Chaurasia, P. K. Srivastava, and A. Mishra, “Graphene-silymarin-loaded chitosan/gelatin/hyaluronic acid hybrid constructs for advanced full-thickness burn wound management,” Int. J. Pharm., vol. 659, p. 124238, Jun. 2024, doi: 10.1016/j.ijpharm.2024.124238.
[10] Shukla, P., Srivastava, P. & Mishra, A. On the potential activity of hyaluronic acid as an antimicrobial agent: experimental and computational validations. Bioprocess Biosyst Eng (2024). https://doi.org/10.1007/s00449-024-03091-4
[11] Saini, R., Kumari, S., Bhatnagar, A. et al. Discovery of the allosteric inhibitor from actinomyces metabolites to target EGFRCSTMLR mutant protein: molecular modeling and free energy approach. Sci Rep 13, 8885 (2023). https://doi.org/10.1038/s41598-023-33065-7
[12] R. Saini, S. Kumari, A. Singh, and A. Mishra, “From nature to cancer therapy: Evaluating the Streptomyces clavuligerus secondary metabolites for potential protein kinase inhibitors,” J. Cell. Biochem., vol. 125, no. 1, p. e30501, 2024, doi: 10.1002/jcb.30501.
[13] Kumari, S., Saini, R., Bhatnagar, A., & Mishra, A. (2023). A comprehensive review on ayurvedic herb Leptadenia reticulata (Jeevanti): a phytochemistry and pharmacological perspective. Natural Product Research, 38(23), 4234–4260. https://doi.org/10.1080/14786419.2023.2282119
[14] Kumari, S., Saini, R., Bhatnagar, A., & Mishra, A. (2023). Exploring plant-based alpha-glucosidase inhibitors: promising contenders for combatting type-2 diabetes. Archives of Physiology and Biochemistry, 130(6), 694–709. https://doi.org/10.1080/13813455.2023.2262167
[15] A. D. Tripathi, S. Katiyar, and A. Mishra, “Glypican1: A potential cancer biomarker for nanotargeted therapy,” Drug Discov. Today, vol. 28, no. 8, p. 103660, Aug. 2023, doi: 10.1016/j.drudis.2023.103660.
[16] Soumya Katiyar1, Shikha Kumari2, Ritika Singh3, Abhay Dev Tripathi4, Divakar Singh5, Pradeep K. Srivastava6, Abha Mishra7, “Recent Advances in the Application of Nano-Biosensor in Tissue Engineering,” in Recent Advances in Biosensor Technology: Volume 1, Bentham Science Publishers, 2023, pp. 112–146. [Online]. Available: DOI: https://doi.org/10.2174/97898151237391230101
[17] Shukla, P., Srivastava, P., Mishra, A. (2023). Hyaluronic Acid Microbial Synthesis and Its Explicit Uses in the Development of Nutraceuticals, Biomedicine, and Vaccine Development. In: Verma, P. (eds) Industrial Microbiology and Biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-99-2816-3_13
[18] A. Bhatnagar and A. Mishra, “Development of Daruharidra (Berberis aristata) Based Biogenic Cadmium Sulfide Nanoparticles: Their Implementation as Antibacterial and Novel Therapeutic Agents against Human Breast and Ovarian Cancer,” http://www.eurekaselect.com, Accessed: Dec. 29, 2024. [Online]. Available: https://www.eurekaselect.com/article/136173
[19] A. Mishra and A. Bhatnagar, “23 - Green synthesis of nanoparticles by endophytes,” in Endophytic Association: What, Why and How, M. Shah and D. Deka, Eds., in Developments in Applied Microbiology and Biotechnology. , Academic Press, 2023, pp. 487–502. doi: 10.1016/B978-0-323-91245-7.00013-4.
[20] A. Bhatnagar, R. Saini, P. Dagar, and A. Mishra, “Molecular modelling and in vitro studies of Daruharidra as a potent alpha-amylase inhibitor,” J. Biomol. Struct. Dyn., vol. 41, no. 9, pp. 3872–3883, Jun. 2023, doi: 10.1080/07391102.2022.2058093.
[21] A. Bhatnagar, E. Tamboli, and A. Mishra, “Wastewater treatment and Mycoremediation by P. ostreatus mycelium,” IOP Conf. Ser. Earth Environ. Sci., vol. 775, no. 1, p. 012003, Jun. 2021, doi: 10.1088/1755-1315/775/1/012003.
Indo-US Conference on Bioengineering and Regenerative Medicine, ICBR-20, 27-29Feb, School of Biochemical Engineering, Organizing Secretary.
PG dissertation guided-55 Awarded; 04 ongoing
Ph.D.s- 09 as Supervisor (awarded); 03 submitted; 04 ongoing
Ph.D. students Co-guided: 09 (04 awarded; 05ongoing)
S.No. |
Project title |
Funding agency |
Status (Ongoing/completed/ Submitted) |
1. |
Production of epsilon poly lysine and its specific conjugates for effective drug targeting, |
DRDO |
Completed |
2. |
Studies on production and properties of glucoamylase by some new isolates of Aspergillus oryzae using agro-industrial waste in solid state fermentation, |
UGC |
Completed |
3. |
Targeted drug delivery of methotrexate / gallic acid folate conjugated Poly L-Lysine nanoparticles |
DBT |
Completed (Sept 2018-Sept 2021) |
4. |
Transcriptome analysis of Cancer cell line treated with Gedunin and ZINC000045971961 as novel Bruton’s tyrosine kinase (BTK) inhibitor |
LSRB, DRDO
|
Ongoing (June 2023- July 2026) |
5. |
Designing and fabrication of norfloxacin cunps and EGF loaded multilayered wound dressing for diabetic burn wound |
CSIR |
Ongoing (Sept 2024-Sept 2026) |
6. |
Development of a nanostructured graphene oxide/polydopamine coated nano-biosensor monitoring GPC1 for the early diagnosis of pancreatic cancer, |
ICMR |
Ongoing (Nov 2024-Nov 2027) |
S.No. |
Student Name |
Year of Joining |
Designation |
1. |
Ravi Saini |
2018 |
PhD |
2. |
Abhay Dev tripathi |
2020 |
PhD |
3. |
Sonali Kumari |
2020 |
PhD |
4. |
Shruti Raut |
2023 |
PhD |
5. |
Arpit Sharma |
2023 |
PhD |
6. |
Aishwarya Kesari |
2024 |
PhD |
7. |
Dr. Alok Shukla |
2024 |
RA |
8. |
Shivani Gupta |
2024 |
Project-JRF |
9. |
Ravi |
2024 |
PhD |